Review: taking Benzonatate and Mucinex dm together


Summary

Drug interactions are reported among people who take Benzonatate and Mucinex dm together. This review analyzes the effectiveness and drug interactions between Benzonatate and Mucinex dm. It is created by eHealthMe based on reports of 43 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Benzonatate and Mucinex dm >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Benzonatate

Benzonatate has active ingredients of benzonatate. It is often used in cough. (latest outcomes from Benzonatate 2,291 users)

Mucinex Dm

Mucinex dm has active ingredients of dextromethorphan hydrobromide; guaifenesin. It is often used in cough. (latest outcomes from Mucinex dm 787 users)

On Aug, 18, 2016

43 people who take Benzonatate, Mucinex Dm are studied.


Number of reports submitted per year:

Benzonatate and Mucinex dm drug interactions.

Drug effectiveness over time:

Benzonatate:
  • < 1 month: 11.0% - (1 of 9 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Mucinex Dm:
  • < 1 month: 0.0% - (0 of 8 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Benzonatate:
  • female: 22.0% - (2 of 9 people)
  • male: 0.0% - (0 of 2 people)
Mucinex Dm:
  • female: 0.0% - (0 of 9 people)
  • male: 0.0% - (0 of 2 people)

Drug effectiveness by age:

Benzonatate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 3 people)
  • 30-39: 66.0% - (2 of 3 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 2 people)
Mucinex Dm:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 3 people)
  • 30-39: 0.0% - (0 of 3 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 2 people)

Most common drug interactions over time *:

1 - 6 months:
  • dizziness
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • fever
  • nausea
  • slurred speech
6 - 12 months:
  • tiredness
not specified:
  • pulmonary hypertension
  • asthenia
  • anxiety
  • pain
  • decreased appetite
  • malignant pleural effusion
  • deep vein thrombosis
  • dyspnoea
  • hypoxia
  • pulmonary embolism

Most common drug interactions by gender *:

female:
  • pain
  • cerebrovascular accident
  • alanine aminotransferase increased
  • anuria
  • aspartate aminotransferase increased
  • blood ph decreased
  • brain death
  • brain oedema
  • cardiac arrest
  • cardiac failure congestive
male:
  • deep vein thrombosis
  • dyspnoea
  • hypoxia
  • pulmonary embolism
  • pulmonary hypertension
  • anxiety
  • asthenia
  • decreased appetite
  • malignant pleural effusion
  • pneumonia

Most common drug interactions by age *:

10-19:
  • completed suicide
  • alanine aminotransferase increased
  • anuria
  • aspartate aminotransferase increased
  • blood ph decreased
  • brain death
  • brain oedema
  • cardiac arrest
  • coma
  • convulsion
20-29:
  • fever
  • nausea
30-39:
  • cardiac failure congestive
  • death
  • disseminated intravascular coagulation
  • febrile neutropenia
  • injury
  • multi-organ failure
  • sepsis
  • anxiety
  • blindness
  • cerebrovascular accident
50-59:
  • deep vein thrombosis
  • dyspnoea
  • hypoxia
  • pulmonary embolism
  • pulmonary hypertension
  • anxiety
  • asthenia
  • decreased appetite
  • malignant pleural effusion
  • pneumonia
60+:
  • pain
  • aphasia
  • asthenia
  • atrial fibrillation
  • carotid artery stenosis
  • cerebral atrophy
  • cerebral ischaemia
  • cerebrovascular accident
  • confusional state
  • dysarthria

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Benzonatate and Mucinex dm?

Can you answer these questions?

More questions for: Benzonatate, Mucinex dm

You may be interested in these reviews

More reviews for: Benzonatate, Mucinex dm

On eHealthMe, Benzonatate (benzonatate) is often used to treat cough. Mucinex dm (dextromethorphan hydrobromide; guaifenesin) is often used to treat cough. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.